Pancreatectomy involves the surgical removal of all or part of the pancreas, which may be required for the treatment of a variety of conditions, such as benign pancreatic tumors, pancreatic cancer, and pancreatitis.

Following a pancreatectomy, the body is unable to produce insulin and even patients that were not previously diabetic must take insulin and enzyme supplements.

Orgenesis technology could overcome this complication, in the same way as in insulin dependent diabetes patients.